Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This study compares pharmacokinetic profiles of tobramycin delivered by TobrAir® 6.0 device
with TOBI® nebulizer system and the TOBI® Podhaler™ device. In addition, lung deposition of
tobramycin delivered by TobrAir® 6.0 device and by TOBI® nebulizer system will be determined.